Axsome obtains exclusive global rights to AZD7325, a novel oral selective GABAA α2,3 receptor positive allosteric modulator ...

Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced that its lead product candidate, NRTX-1001, ...

For the millions of people worldwide living with severe forms of epilepsy, some do not respond to medication and it can be ...

As National Epilepsy Awareness Month begins on Saturday, new survey findings from SK Life Science, Inc., a global leader in ...

Scientists from Laval University and the University of Texas Southwestern Medical Center have joined forces to understand ...

Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn't stop seizures for everyone and ...

Patients with treatment-resistant epilepsy often cycle through multiple medications as they seek relief from the seizures ...

Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn’t stop seizures for everyone and ...

Epilepsy is a chronic disease of the central nervous system characterized by recurrent seizures. It is a very common neurological disorder, affecting about 50 million people worldwide. With timely ...

In today’s Health Headlines, can treatment-resistant epilepsy improve over time? Are melatonin supplements bad for your heart? And what resources are available for people who rely on emergency rooms ...

Veterans who develop epilepsy following a traumatic brain injury (TBI) face a higher risk of death than veterans with ...

Treatment of epilepsy involves medications as well as surgical methods. There should be a complete care plan of treatment for epileptics that addresses lifestyle issues as well as medical issues.